Next Article in Journal
Heterocycles in Peptidomimetics and Pseudopeptides: Design and Synthesis
Next Article in Special Issue
Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines
Previous Article in Journal
Receptor and Channel Heteromers as Pain Targets
Previous Article in Special Issue
Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation
Pharmaceuticals 2012, 5(3), 279-296; doi:10.3390/ph5030279

Notes on Article Versions

Action Date Notes Link
article html file updated 23 January 2013 10:58 CET Original file -
article html file updated 26 January 2013 08:24 CET Update -
article html file updated 29 January 2013 01:55 CET Update -
article html file updated 6 February 2013 06:15 CET Update -
article html file updated 7 February 2013 00:53 CET Update -
article html file updated 7 February 2013 10:46 CET Update -
article xml file uploaded 6 August 2013 16:02 CEST Original file http://www.mdpi.com/1424-8247/5/3/279/xml
article html file updated 6 August 2013 16:02 CEST Update -
article html file updated 16 June 2015 21:58 CEST Update http://www.mdpi.com/1424-8247/5/3/279/html
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert